Reactions Weekly

, Volume 1710, Issue 1, pp 7–7 | Cite as

Insulin degludec reduces risk of severe hypoglycaemia

Clinical study


  1. PRATLEY RE, et al. Cardiovascular (CV) Safety and Severe Hypoglycemia Benefit of Insulin Degludec vs. Insulin Glargine U100 in Older Patients (≥65 Years) with Type 2 Diabetes (T2D) - Observations from DEVOTE 78th Annual Scientific Sessions of the American Diabetes Association : abstr. 108-OR, 22 Jun 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations